PrEP Promotion for Human Immunodeficiency Virus Infection
Study Summary
This trial aims to reduce HIV incidence among Latino gay men by training siblings to promote PrEP use. Control group will talk about vaccines to prevent other diseases.
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Does the eligibility criteria for this clinical trial encompass individuals aged thirty and above?
"As specified by the inclusion criteria, only individuals aged between 18 and 39 are eligible for this trial. Conversely, there are 112 trials specifically tailored to minors and 338 studies reserved for geriatric patients."
How many individuals are contributing to this research effort?
"Affirmative. Per the information sourced on clinicaltrials.gov, this medical trial is actively looking for participants and was first posted to the website on April 15th 2023. Last updated on 4/6/2023, it seeks 248 patients from a single site of recruitment."
Is the recruitment period of this trial still ongoing?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial is actively recruiting participants, which began on April 15th 2023 and was last updated 6 days later. The study has a requirement of 248 patients from 1 medical centre."
Is it possible to join the research trial?
"In order to have the opportunity to participate, applicants must be infected with HIV and between 18-39 years of age. There is an overall target recruitment quota of 248 patients for this trial."